PL1678182T3 - Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn - Google Patents

Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Info

Publication number
PL1678182T3
PL1678182T3 PL04796445T PL04796445T PL1678182T3 PL 1678182 T3 PL1678182 T3 PL 1678182T3 PL 04796445 T PL04796445 T PL 04796445T PL 04796445 T PL04796445 T PL 04796445T PL 1678182 T3 PL1678182 T3 PL 1678182T3
Authority
PL
Poland
Prior art keywords
triazolo
pyrazolo
pyrimidines
amino
preparing substituted
Prior art date
Application number
PL04796445T
Other languages
English (en)
Inventor
Shen-Chun Kuo
David Jieh-Shyh Tsai
Loc Thanh Tran
Pengyi Zhang
Andrew D Jones
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL1678182T3 publication Critical patent/PL1678182T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL04796445T 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn PL1678182T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28
EP04796445A EP1678182B1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines
PCT/US2004/035472 WO2005044819A1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Publications (1)

Publication Number Publication Date
PL1678182T3 true PL1678182T3 (pl) 2007-05-31

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04796445T PL1678182T3 (pl) 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Country Status (18)

Country Link
US (4) US7223861B2 (pl)
EP (1) EP1678182B1 (pl)
JP (2) JP4782693B2 (pl)
CN (2) CN101899050A (pl)
AR (1) AR046560A1 (pl)
AT (1) ATE353331T1 (pl)
CA (1) CA2543431A1 (pl)
CY (1) CY1106393T1 (pl)
DE (1) DE602004004677T2 (pl)
DK (1) DK1678182T3 (pl)
ES (1) ES2278353T3 (pl)
HR (1) HRP20070063T3 (pl)
MX (1) MXPA06004722A (pl)
PL (1) PL1678182T3 (pl)
PT (1) PT1678182E (pl)
SI (1) SI1678182T1 (pl)
WO (1) WO2005044819A1 (pl)
ZA (1) ZA200603307B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60110219T2 (de) * 2000-05-26 2006-03-09 Schering Corp. Adenosin a2a rezeptor antagonisten
ES2278353T3 (es) * 2003-10-28 2007-08-01 Schering Corporation Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas.
EP2258372B8 (en) 2005-06-07 2012-12-19 Kyowa Hakko Kirin Co., Ltd. A2A antagonists for use in the treatment of motor disorders
US8598343B2 (en) * 2009-08-07 2013-12-03 Merck Sharp & Dohme Corp. Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
US9529039B2 (en) 2012-05-10 2016-12-27 Unitechno, Inc. Semiconductor transporting and testing fixture
RU2732404C2 (ru) * 2014-09-26 2020-09-16 Ф. Хоффманн-Ля Рош Аг СПОСОБЫ ПОЛУЧЕНИЯ (ЦИКЛОПЕНТИЛ[d]ПИРИМИДИН-4-ИЛ)ПИПЕРАЗИНОВЫХ СОЕДИНЕНИЙ
US12414952B2 (en) 2018-11-20 2025-09-16 Merck Sharp & Dohme Llc Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
AU2019383948A1 (en) 2018-11-20 2021-05-20 Merck Sharp & Dohme Llc Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
WO2020112700A1 (en) 2018-11-30 2020-06-04 Merck Sharp & Dohme Corp. 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
AU2019388872A1 (en) 2018-11-30 2021-05-27 Merck Sharp & Dohme Llc 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
DE60110219T2 (de) * 2000-05-26 2006-03-09 Schering Corp. Adenosin a2a rezeptor antagonisten
KR20030076633A (ko) 2001-02-05 2003-09-26 가부시키 가이샤 오오쯔카 세이야쿠 고우죠우 트리아조로퀴나졸린 및 피라졸로 트리아조로피리미딘유도체, 의약조성물,아데노신 에이3 수용체 친화제,안압저하제, 녹내장의 예방 및 치료를 위한 제제 및안압저하 방법
EP1392704B1 (en) * 2001-05-01 2006-02-22 Astellas Pharma Inc. Cephem compounds
IL161716A0 (en) * 2001-11-30 2004-09-27 Schering Corp ADENOSINE A2a RECEPTOR ANTAGONISTS
ES2278353T3 (es) * 2003-10-28 2007-08-01 Schering Corporation Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas.
CA2547248A1 (en) * 2003-12-01 2005-06-16 Schering Corporation Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Also Published As

Publication number Publication date
EP1678182B1 (en) 2007-02-07
US20090326241A1 (en) 2009-12-31
HRP20070063T3 (hr) 2007-04-30
CN1898246B (zh) 2010-10-27
ATE353331T1 (de) 2007-02-15
US7223861B2 (en) 2007-05-29
ES2278353T3 (es) 2007-08-01
JP4782693B2 (ja) 2011-09-28
PT1678182E (pt) 2007-04-30
CN1898246A (zh) 2007-01-17
US7601833B2 (en) 2009-10-13
US20050090492A1 (en) 2005-04-28
DE602004004677T2 (de) 2007-11-15
JP2007509948A (ja) 2007-04-19
HK1086008A1 (en) 2006-09-08
CA2543431A1 (en) 2005-05-19
CN101899050A (zh) 2010-12-01
US7439361B2 (en) 2008-10-21
US20070203340A1 (en) 2007-08-30
US20090005559A1 (en) 2009-01-01
WO2005044819A1 (en) 2005-05-19
DE602004004677D1 (de) 2007-03-22
EP1678182A1 (en) 2006-07-12
DK1678182T3 (da) 2007-06-04
AR046560A1 (es) 2005-12-14
ZA200603307B (en) 2008-07-30
SI1678182T1 (sl) 2007-06-30
MXPA06004722A (es) 2006-07-05
CY1106393T1 (el) 2011-10-12
JP2011116795A (ja) 2011-06-16

Similar Documents

Publication Publication Date Title
IL182177A0 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
TWI365189B (en) Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives
EP1599482A4 (en) PYRAZOLO1,5-A PYRIMIDINE DERIVATIVES
ZA200702541B (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones
IL160878A0 (en) Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
IL175812A0 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
PL379009A1 (pl) Pochodne pirazolo [1,5-a] [1,3,5] triazyny jako ligandy receptora kanabinoidowego
EP1653969A4 (en) PYRROLO 1,2-B PYRIDAZINE DERIVATIVES
IL220174A0 (en) 5-AMINO - {PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE}-2-AND 7-SUBSTITUTED DERIVATIVES AS ADENOSINE A2A RECEPTOR INHIBITORS
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
IL178674A0 (en) PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS
ZA200604960B (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-A]pyrimidin-6-onederivatives
ZA200708524B (en) Process for preparing pyrido[2,3-D]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one derivatives
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
PT1622912E (pt) Antagonistas 2-alcinil- e 2-alcenilpirazolo-[4,3-b]-1,2,4- triazolo-[1,5-c]-pirimidina do receptor a2a da adenosina
PL1678182T3 (pl) Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn
WO2005054245A3 (en) Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
PL370565A1 (pl) Pochodne 5-metoksy-8-arylo[1,2,4]triazolo[1,5-a]pirydyny
HUP0301399A3 (en) Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine
GB2424883B (en) Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
IL176471A0 (en) Process for the preparation of triazolopyrimidines
ZA200600471B (en) 7-substituted 3-nitro-pyrazolo[1,5-A] pyrimidines
IL189370A0 (en) PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND